Jon Lim, MRCP PhD
@drjonlim.bsky.social
Senior Lecturer & Consultant Medical Oncologist in Advanced #Immunotherapy + #CellTherapy at The University of Manchester & The Christie • MANIFEST Deputy Lead • ESMO #TranslationalResearch Faculty Lead
🔗 Bio: bit.ly/Christie_JonLim
(tennis enthusiast 🎾)
🔗 Bio: bit.ly/Christie_JonLim
(tennis enthusiast 🎾)
Pinned
It's #WorldCancerDay.
So thought it'd be a good idea to update the #StarterPack for #CancerImmunology - our #ImmunoSky #CanSky #OncSky #MedSky #AcademicSky communities are growing 📈 - we are now on Pack 3!
🧑🔬 Pack 1
go.bsky.app/Jm8JWdM
🧑🔬 Pack 2
go.bsky.app/VCtk6Qd
🧑🔬 Pack 3
go.bsky.app/NR7fy4u
So thought it'd be a good idea to update the #StarterPack for #CancerImmunology - our #ImmunoSky #CanSky #OncSky #MedSky #AcademicSky communities are growing 📈 - we are now on Pack 3!
🧑🔬 Pack 1
go.bsky.app/Jm8JWdM
🧑🔬 Pack 2
go.bsky.app/VCtk6Qd
🧑🔬 Pack 3
go.bsky.app/NR7fy4u
🌍 This is one of the projects I’m most proud of since returning to Manchester 🇬🇧 🤝 🇺🇦. Huge thanks to Rachel, Harry, Jenny, Su, Prof Aziz, Prof Choudhury, Prof Cowan & many other #TeamManchester 🐝 colleagues at The Christie for making this happen.
More to come - watch the space!
More to come - watch the space!
If you’ve been following us these last few weeks you’ll have seen our first two cohorts of Ukrainian Observers arrive at from @nci_ukraine
Take a look at this news feauture for a closer look at what they have been up to.
@drjonlim.bsky.social
#cancercare #cancereducation #internationaleducation
Take a look at this news feauture for a closer look at what they have been up to.
@drjonlim.bsky.social
#cancercare #cancereducation #internationaleducation
December 19, 2025 at 5:23 PM
🌍 This is one of the projects I’m most proud of since returning to Manchester 🇬🇧 🤝 🇺🇦. Huge thanks to Rachel, Harry, Jenny, Su, Prof Aziz, Prof Choudhury, Prof Cowan & many other #TeamManchester 🐝 colleagues at The Christie for making this happen.
More to come - watch the space!
More to come - watch the space!
Wise and timely words from Rathmell & Shevde! Thanks for advocating for early career researchers - including clinical academics.
If we truly care about the future of science and patient impact, investing in people has to come first - not as rhetoric, but as action 🙌 .
If we truly care about the future of science and patient impact, investing in people has to come first - not as rhetoric, but as action 🙌 .
Flipping the narrative on launching a rewarding career in academic medicine - Nature Cancer
Fostering a nimble, innovative and resilient biomedical workforce is crucial. Here, we consider how to accelerate the readiness of early career investigators to lead, inverting the traditional pyramid...
www.nature.com
December 14, 2025 at 11:00 PM
Wise and timely words from Rathmell & Shevde! Thanks for advocating for early career researchers - including clinical academics.
If we truly care about the future of science and patient impact, investing in people has to come first - not as rhetoric, but as action 🙌 .
If we truly care about the future of science and patient impact, investing in people has to come first - not as rhetoric, but as action 🙌 .
Hear more about RISE + why tackling safety/toxicity in advanced therapies is centre to our programme.
We're humbled to hear from Elkie Mellor, who generously shared her lived experience. Voices like hers are a powerful reminder of why this work matters & will continue to motivate everything we do.
We're humbled to hear from Elkie Mellor, who generously shared her lived experience. Voices like hers are a powerful reminder of why this work matters & will continue to motivate everything we do.
Major study launched to make advanced cancer treatments safer for patients
A major new UK study, led by The Christie NHS Foundation Trust and The University of Manchester, has been launched to help patients with cancer better tolerate cutting-edge immunotherapy treatments li...
www.christie.nhs.uk
December 12, 2025 at 5:22 PM
Hear more about RISE + why tackling safety/toxicity in advanced therapies is centre to our programme.
We're humbled to hear from Elkie Mellor, who generously shared her lived experience. Voices like hers are a powerful reminder of why this work matters & will continue to motivate everything we do.
We're humbled to hear from Elkie Mellor, who generously shared her lived experience. Voices like hers are a powerful reminder of why this work matters & will continue to motivate everything we do.
🚀 Excited to share the launch of our RISE consortium.
RISE unites NHS, academic & industry partners to tackle immune-related toxicities in advanced cancer therapies, incl. CRS & neurotoxicity - centred around patient safety + quality of life.
Funded by @ukri.org MRC Prosperity Partnership Award.
RISE unites NHS, academic & industry partners to tackle immune-related toxicities in advanced cancer therapies, incl. CRS & neurotoxicity - centred around patient safety + quality of life.
Funded by @ukri.org MRC Prosperity Partnership Award.
RISE Manchester | LinkedIn
RISE Manchester | 44 followers on LinkedIn. Making advanced cancer therapies safer through science, innovation and partnership. | RISE (Reducing Immune Stress from Excess cytokine release in advanced ...
www.linkedin.com
December 12, 2025 at 5:17 PM
🚀 Excited to share the launch of our RISE consortium.
RISE unites NHS, academic & industry partners to tackle immune-related toxicities in advanced cancer therapies, incl. CRS & neurotoxicity - centred around patient safety + quality of life.
Funded by @ukri.org MRC Prosperity Partnership Award.
RISE unites NHS, academic & industry partners to tackle immune-related toxicities in advanced cancer therapies, incl. CRS & neurotoxicity - centred around patient safety + quality of life.
Funded by @ukri.org MRC Prosperity Partnership Award.
'Neoadjuvant immunotherapy continues to rewrite our understanding of anticancer immunity'
Check out my #ESMODailyReporter editorial on some of the abstracts presented at this year's #ESMOImmuno25 in London 👇
Check out my #ESMODailyReporter editorial on some of the abstracts presented at this year's #ESMOImmuno25 in London 👇
#ESMODailyReporter: Jon Lim, MRCP PhD discusses the use of single-cell spatial transcriptomics and proteomic profiling to dissect why #immunotherapy works in some tumours but not others, highlighting neoadjuvant studies at #ESMOImmuno25 #ImmunoOncology
➡️ https://ow.ly/kwgt50XGX4M
➡️ https://ow.ly/kwgt50XGX4M
December 10, 2025 at 5:07 PM
'Neoadjuvant immunotherapy continues to rewrite our understanding of anticancer immunity'
Check out my #ESMODailyReporter editorial on some of the abstracts presented at this year's #ESMOImmuno25 in London 👇
Check out my #ESMODailyReporter editorial on some of the abstracts presented at this year's #ESMOImmuno25 in London 👇
✨ #ESMOImmuno25
@turajliclab.bsky.social presented the MANIFEST platform, recent progress & our ambitions at ESMO IO Congress here in London.
The message from the 'Special Session with Industry': cross-sector collaboration is critical to accelerate discovery & develop safer/effective therapies.
@turajliclab.bsky.social presented the MANIFEST platform, recent progress & our ambitions at ESMO IO Congress here in London.
The message from the 'Special Session with Industry': cross-sector collaboration is critical to accelerate discovery & develop safer/effective therapies.
December 10, 2025 at 4:58 PM
✨ #ESMOImmuno25
@turajliclab.bsky.social presented the MANIFEST platform, recent progress & our ambitions at ESMO IO Congress here in London.
The message from the 'Special Session with Industry': cross-sector collaboration is critical to accelerate discovery & develop safer/effective therapies.
@turajliclab.bsky.social presented the MANIFEST platform, recent progress & our ambitions at ESMO IO Congress here in London.
The message from the 'Special Session with Industry': cross-sector collaboration is critical to accelerate discovery & develop safer/effective therapies.
Really looking forward to catching up with colleagues and friends at #ESMOImmuno25 in London.
If you’re attending, please stop by our team’s poster - presented by our Specialist Pharmacist Ragini Jethra. We highlight new insights from our systematic review on the safety profile of TIL therapy.
If you’re attending, please stop by our team’s poster - presented by our Specialist Pharmacist Ragini Jethra. We highlight new insights from our systematic review on the safety profile of TIL therapy.
December 9, 2025 at 1:54 PM
Really looking forward to catching up with colleagues and friends at #ESMOImmuno25 in London.
If you’re attending, please stop by our team’s poster - presented by our Specialist Pharmacist Ragini Jethra. We highlight new insights from our systematic review on the safety profile of TIL therapy.
If you’re attending, please stop by our team’s poster - presented by our Specialist Pharmacist Ragini Jethra. We highlight new insights from our systematic review on the safety profile of TIL therapy.
Reposted by Jon Lim, MRCP PhD
If you're looking for careers support our 2026 mentoring scheme applications close on December 10 2025. Learn more here: www.immunology.org/careers/bsi-...
BSI mentoring scheme | British Society for Immunology
www.immunology.org
December 3, 2025 at 11:56 AM
If you're looking for careers support our 2026 mentoring scheme applications close on December 10 2025. Learn more here: www.immunology.org/careers/bsi-...
🩺 Fantastic opportunity for #YoungOncologists: ICF-ESMO programme for an 8-week observership.
We've excellent opportunities here in Manchester & would be happy to support (✉️: the-christie.observers@nhs.net).
@christieinstitute.bsky.social
@myesmo.bsky.social
📥 For more info (due 25 Jan 2026) 👇
We've excellent opportunities here in Manchester & would be happy to support (✉️: the-christie.observers@nhs.net).
@christieinstitute.bsky.social
@myesmo.bsky.social
📥 For more info (due 25 Jan 2026) 👇
www.esmo.org
December 1, 2025 at 11:36 AM
🩺 Fantastic opportunity for #YoungOncologists: ICF-ESMO programme for an 8-week observership.
We've excellent opportunities here in Manchester & would be happy to support (✉️: the-christie.observers@nhs.net).
@christieinstitute.bsky.social
@myesmo.bsky.social
📥 For more info (due 25 Jan 2026) 👇
We've excellent opportunities here in Manchester & would be happy to support (✉️: the-christie.observers@nhs.net).
@christieinstitute.bsky.social
@myesmo.bsky.social
📥 For more info (due 25 Jan 2026) 👇
Reposted by Jon Lim, MRCP PhD
Excited about not one but 2 fantastic conferences in Manchester! So timely as cell therapies are on the standard care horizon!
...and don’t miss our TIL Summit 2026, taking place the day before (11 Mar 2026), also at the Midland Hotel.
A dedicated forum bringing together UK & international leaders to discuss TIL therapy, manufacturing, biomarkers, and next-generation trials 👇
A dedicated forum bringing together UK & international leaders to discuss TIL therapy, manufacturing, biomarkers, and next-generation trials 👇
🚀 Save the Date!
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
November 30, 2025 at 2:28 PM
Excited about not one but 2 fantastic conferences in Manchester! So timely as cell therapies are on the standard care horizon!
⏰ Calling all melanoma enthusiasts!
The abstract submission deadline for the inaugural “Lab to Life: Innovations in Melanoma Research Conference UK 2026” has been extended to 19 December 2025!
Happening 12-13 March 2026 at The Midland Hotel, Manchester.
Submit your abstract and register here:
The abstract submission deadline for the inaugural “Lab to Life: Innovations in Melanoma Research Conference UK 2026” has been extended to 19 December 2025!
Happening 12-13 March 2026 at The Midland Hotel, Manchester.
Submit your abstract and register here:
Home
Lab to Life: Innovations in Melanoma is a UK conference in Manchester on cutting-edge melanoma research, translational science and advances in treatments.
sites.manchester.ac.uk
November 30, 2025 at 2:08 PM
⏰ Calling all melanoma enthusiasts!
The abstract submission deadline for the inaugural “Lab to Life: Innovations in Melanoma Research Conference UK 2026” has been extended to 19 December 2025!
Happening 12-13 March 2026 at The Midland Hotel, Manchester.
Submit your abstract and register here:
The abstract submission deadline for the inaugural “Lab to Life: Innovations in Melanoma Research Conference UK 2026” has been extended to 19 December 2025!
Happening 12-13 March 2026 at The Midland Hotel, Manchester.
Submit your abstract and register here:
Reposted by Jon Lim, MRCP PhD
🧬 CAR T treatments improve overall survival for patients with large B-cell lymphoma and progression-free survival for patients with multiple myeloma.
Save this Review for your bibliography:
ja.ma/49HHc34
Save this Review for your bibliography:
ja.ma/49HHc34
November 29, 2025 at 1:00 PM
🧬 CAR T treatments improve overall survival for patients with large B-cell lymphoma and progression-free survival for patients with multiple myeloma.
Save this Review for your bibliography:
ja.ma/49HHc34
Save this Review for your bibliography:
ja.ma/49HHc34
🚀 Save the Date!
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
November 29, 2025 at 11:05 AM
🚀 Save the Date!
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
End of an era! @marianapdc.bsky.social is one of the most talented scientists I have ever met; beyond that a super good friend 🙌. So honoured to have overlapped in the lab with you, and see you shine and rise to all the successes you so deserve. Thanks for all the wonderful times.
All the best! 💫
All the best! 💫
Yesterday marked the end of an almost 7 year era in the @reisesousalab.bsky.social at the @crick.ac.uk 🥹 Feeling immensely grateful to Caetano for his incredible mentorship and guidance, and for fostering the most collaborative and supportive scientific atmosphere in the lab 🌟
November 27, 2025 at 11:18 PM
End of an era! @marianapdc.bsky.social is one of the most talented scientists I have ever met; beyond that a super good friend 🙌. So honoured to have overlapped in the lab with you, and see you shine and rise to all the successes you so deserve. Thanks for all the wonderful times.
All the best! 💫
All the best! 💫
Reposted by Jon Lim, MRCP PhD
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his future after he received a revolutionary stem cell gene therapy treatment developed by researchers at the University of Manchester.
www.bbc.co.uk/news/article...
www.bbc.co.uk/news/article...
Hunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy
Oliver has an inherited condition called Hunter syndrome, which causes progressive damage to the body and brain.
www.bbc.co.uk
November 24, 2025 at 11:31 AM
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his future after he received a revolutionary stem cell gene therapy treatment developed by researchers at the University of Manchester.
www.bbc.co.uk/news/article...
www.bbc.co.uk/news/article...
Reposted by Jon Lim, MRCP PhD
Levy on international students’ tuition fees not in best interest of UK, says @duncanivison.bsky.social, president and VC of @manchester.ac.uk
More from @theguardian.com
bit.ly/4r1save
#education #educationnews
More from @theguardian.com
bit.ly/4r1save
#education #educationnews
Levy on international students’ tuition fees not in best interest of UK, says leader of top university
Duncan Ivison, president of Manchester University, says government’s 6% surcharge plan will ‘hurt the sector’
bit.ly
November 17, 2025 at 12:00 PM
Levy on international students’ tuition fees not in best interest of UK, says @duncanivison.bsky.social, president and VC of @manchester.ac.uk
More from @theguardian.com
bit.ly/4r1save
#education #educationnews
More from @theguardian.com
bit.ly/4r1save
#education #educationnews
Fantastic opportunity from @turajliclab.bsky.social! 🚀
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
MI/25/63 Associate Scientist | Cancer Research UK Manchester Institute
We are seeking a highly motivated and accomplished Associate Scientist to help lead and shape the programme. You will act as an operational deputy to Professor Samra Turajlic, helping to bridge activi...
www.cruk.manchester.ac.uk
November 16, 2025 at 5:36 PM
Fantastic opportunity from @turajliclab.bsky.social! 🚀
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
The CanDy Lab is recruiting an Associate Scientist to drive cutting-edge cancer research across @cruk-mi.bsky.social and @crick.ac.uk.
A rare chance to lead, grow, and shape high-impact science 👇
www.cruk.manchester.ac.uk/career/mi-25...
🚨 Save the Date!
Next #ChristieFellows session:
“Preparing a Grant Proposal for PhD or Research Projects”
🎤 Dr Jamie Weaver
🗓️ Tue 18 Nov 2025 | 12:30–13:30
📍 Seminar 4&5, Edu Centre
Learn how to pitch your idea & navigate the grant process from an early-career clinical academic.
#TeamManchester 🐝
Next #ChristieFellows session:
“Preparing a Grant Proposal for PhD or Research Projects”
🎤 Dr Jamie Weaver
🗓️ Tue 18 Nov 2025 | 12:30–13:30
📍 Seminar 4&5, Edu Centre
Learn how to pitch your idea & navigate the grant process from an early-career clinical academic.
#TeamManchester 🐝
November 12, 2025 at 4:55 PM
🚨 Save the Date!
Next #ChristieFellows session:
“Preparing a Grant Proposal for PhD or Research Projects”
🎤 Dr Jamie Weaver
🗓️ Tue 18 Nov 2025 | 12:30–13:30
📍 Seminar 4&5, Edu Centre
Learn how to pitch your idea & navigate the grant process from an early-career clinical academic.
#TeamManchester 🐝
Next #ChristieFellows session:
“Preparing a Grant Proposal for PhD or Research Projects”
🎤 Dr Jamie Weaver
🗓️ Tue 18 Nov 2025 | 12:30–13:30
📍 Seminar 4&5, Edu Centre
Learn how to pitch your idea & navigate the grant process from an early-career clinical academic.
#TeamManchester 🐝
Reposted by Jon Lim, MRCP PhD
We were proud to see #TeamManchester present at over 10 sessions & 20+ posters at #ESMO2025.
Well done to everyone involved in representing the MCRC on this international stage & demonstrating the commitment of our researchers & clinicians!🐝
See you all in Spain for #ESMO26! 🇪🇸
Well done to everyone involved in representing the MCRC on this international stage & demonstrating the commitment of our researchers & clinicians!🐝
See you all in Spain for #ESMO26! 🇪🇸
October 24, 2025 at 9:38 AM
We were proud to see #TeamManchester present at over 10 sessions & 20+ posters at #ESMO2025.
Well done to everyone involved in representing the MCRC on this international stage & demonstrating the commitment of our researchers & clinicians!🐝
See you all in Spain for #ESMO26! 🇪🇸
Well done to everyone involved in representing the MCRC on this international stage & demonstrating the commitment of our researchers & clinicians!🐝
See you all in Spain for #ESMO26! 🇪🇸
So proud of my colleague Sacha Howell on this latest @nature.com publication reporting on the Breast Cancer-Anti-Progestin Prevention Study 1 (BC-APPS1) - many years in the making: www.nature.com/articles/s41...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
New study uncovers potential way to prevent breast cancer in pre-menopausal women
A University of Manchester study funded by Breast Cancer Now and supported by Prevent Breast Cancer, reveals a drug approved for use in other conditions could be repurposed to prevent breast cancer in...
www.manchester.ac.uk
November 6, 2025 at 10:04 AM
So proud of my colleague Sacha Howell on this latest @nature.com publication reporting on the Breast Cancer-Anti-Progestin Prevention Study 1 (BC-APPS1) - many years in the making: www.nature.com/articles/s41...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
Press release from The University of Manchester:
www.manchester.ac.uk/about/news/n...
Reposted by Jon Lim, MRCP PhD
#ESMO25: Positive efficacy results without safety concerns seen with NW-301V, a TCR-T therapy targeting KRAS G12V, in patients with KRAS G12V-mutant advanced #GICancer in a phase I #ClinicalTrial.
#ESMODailyReporter🔗 https://ow.ly/jouK50XjATp
Jon Lim, MRCP PhD
#ESMODailyReporter🔗 https://ow.ly/jouK50XjATp
Jon Lim, MRCP PhD
October 30, 2025 at 4:30 PM
#ESMO25: Positive efficacy results without safety concerns seen with NW-301V, a TCR-T therapy targeting KRAS G12V, in patients with KRAS G12V-mutant advanced #GICancer in a phase I #ClinicalTrial.
#ESMODailyReporter🔗 https://ow.ly/jouK50XjATp
Jon Lim, MRCP PhD
#ESMODailyReporter🔗 https://ow.ly/jouK50XjATp
Jon Lim, MRCP PhD
Reposted by Jon Lim, MRCP PhD
We joined forces across Europe to map, connect & accelerate the development of ATMPs — gene, cell and tissue-based therapies that could transform patient care.
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
October 24, 2025 at 10:13 AM
We joined forces across Europe to map, connect & accelerate the development of ATMPs — gene, cell and tissue-based therapies that could transform patient care.
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
We make ATMP innovation faster, safer and more accessible for everyone.
👉 join4atmp.eu
#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation
Reposted by Jon Lim, MRCP PhD
There’s still time to sign up for our Taster Session on Thursday 30 October to learn more about studying a #PhD in Cancer Sciences.
⏰ Learn about our application process
🧑 Hear from current students
🐝 Learn what it’s like to study in Manchester
www.eventbrite.co.uk/e/cruk-mcrc-...
⏰ Learn about our application process
🧑 Hear from current students
🐝 Learn what it’s like to study in Manchester
www.eventbrite.co.uk/e/cruk-mcrc-...
CRUK MCRC PhD Taster Session 2025–2026 : Discover, Apply, Lead
From Curiosity to Cure: Explore PhD Opportunities at CRUK MCRC, Meet the Researchers and Map Your Future
www.eventbrite.co.uk
October 27, 2025 at 9:56 AM
There’s still time to sign up for our Taster Session on Thursday 30 October to learn more about studying a #PhD in Cancer Sciences.
⏰ Learn about our application process
🧑 Hear from current students
🐝 Learn what it’s like to study in Manchester
www.eventbrite.co.uk/e/cruk-mcrc-...
⏰ Learn about our application process
🧑 Hear from current students
🐝 Learn what it’s like to study in Manchester
www.eventbrite.co.uk/e/cruk-mcrc-...
Reposted by Jon Lim, MRCP PhD
Our fourth and final day of #ESMO25! We listened to talks by Consultant & Fellow Alum Melissa Frizziero and Honorary Academic Consultant & Fellowships Specialty Lead for Medical Oncology @drjonlim.bsky.social! We also learned about the various professional development opportunities offered by ESMO 🎓
October 20, 2025 at 2:36 PM
Our fourth and final day of #ESMO25! We listened to talks by Consultant & Fellow Alum Melissa Frizziero and Honorary Academic Consultant & Fellowships Specialty Lead for Medical Oncology @drjonlim.bsky.social! We also learned about the various professional development opportunities offered by ESMO 🎓
Reposted by Jon Lim, MRCP PhD
#ESMO25 Day 3 has been a huge success, with talks from a number of our Fellow Supervisors, including Dr Andrew Clamp presenting original research on the ICON8B trial. We also caught up with some of our current and previous fellows who have been presenting posters at the conference! 📊
October 19, 2025 at 2:41 PM
#ESMO25 Day 3 has been a huge success, with talks from a number of our Fellow Supervisors, including Dr Andrew Clamp presenting original research on the ICON8B trial. We also caught up with some of our current and previous fellows who have been presenting posters at the conference! 📊